Italy, Milan 
Dr. Alessandro Russo is a medical oncologist specializing in thoracic malignancies, with a strong focus on non-small cell lung cancer (NSCLC), liquid biopsy, and translational oncology. His work integrates clinical practice and biomarker-driven research, with active involvement in Phase II–III clinical trials and precision oncology strategies.
Current Position
- Medical Oncology Specialist, Medical Oncology and Oncohematology Unit, Humanitas
Education
- PhD in Medical and Surgical Biotechnologies, University of Messina
- Specialization in Medical Oncology, University of Messina
- MD in Medicine and Surgery, University of Messina
Clinical & Research Focus
- Thoracic and pulmonary malignancies, including NSCLC
- Primary brain tumors
- Liquid biopsy and circulating biomarkers
- Immunotherapy and targeted therapies
- Molecular diagnostics and precision oncology
- Clinical trial development and participation (Phase II–III)
Clinical Experience
- Responsibility for diagnostic and therapeutic pathways in thoracic oncology
- Principal Investigator and sub-investigator in multiple Phase II/III clinical trials
- Management of lung cancer patients and complex oncologic cases
- Participation in multidisciplinary oncology teams
Previous Experience
- Head, Thoracic-Pulmonary Pathology Outpatient Clinic, Medical Oncology Unit, Papardo Hospital, Messina (2020–2024)
- Medical Oncologist, Medical Oncology Unit, Papardo Hospital, Messina
- Visiting Researcher, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore
- Research focus on tumor exosomes, circulating biomarkers, and immunotherapy response in NSCLC
Academic Profile
- Author of numerous peer-reviewed publications in international oncology journals
- Research contributions in liquid biopsy, immunotherapy, and lung cancer biology
- Co-author of book chapters in oncology and immunotherapy
- Active involvement in translational and clinical oncology research
Professional Memberships
- International Society of Liquid Biopsy (ISLB)
- International Association for the Study of Lung Cancer (IASLC)
- Italian Association of Thoracic Oncology (AIOT)
- Italian Association of Medical Oncology (AIOM)
- European Society for Medical Oncology (ESMO)
Areas of Expertise
- Non-small cell lung cancer (NSCLC)
- Liquid biopsy and biomarker development
- Immunotherapy and checkpoint inhibitors
- Targeted therapies and resistance mechanisms
- Translational oncology and precision medicine
All information is sourced from publicly available materials.